OSE2101
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for OSE2101, covering 2024-02-02 to 2026-04-01. Get the full timeline:
Most recent: Clinical Trial Update: Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint Inhibitor [Phase 3]